Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0015 | 0.0145 | 0.0166 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.0145 | 0.0843 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0565 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0029 | 0.0772 | 0.5145 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1664 | 0.1908 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0028 | 0.0724 | 0.4809 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1481 | 1 |
Brugia malayi | intermediate filament protein | 0.0026 | 0.0644 | 0.0646 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0117 | 0.4763 | 0.5463 |
Echinococcus granulosus | lamin | 0.0026 | 0.0644 | 0.4263 |
Brugia malayi | Pre-SET motif family protein | 0.0029 | 0.0772 | 0.0795 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.0145 | 0.0843 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.0644 | 0.4263 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0015 | 0.0145 | 0.0069 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.0644 | 0.0739 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0565 | 0.0649 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.0961 | 0.1014 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0565 | 0.0556 |
Brugia malayi | Pre-SET motif family protein | 0.0203 | 0.8718 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0622 | 0.0713 |
Echinococcus multilocularis | musashi | 0.0026 | 0.0644 | 0.4263 |
Schistosoma mansoni | lamin | 0.0026 | 0.0644 | 0.3735 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0015 | 0.0145 | 0.0069 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0961 | 0.1102 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0029 | 0.0772 | 0.4698 |
Echinococcus multilocularis | lamin | 0.0026 | 0.0644 | 0.4263 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0772 | 0.4698 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1481 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.1481 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.0644 | 0.0646 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.0145 | 0.0843 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0565 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.0565 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 0.0644 | 0.3735 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.1664 | 0.1828 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.1481 | 0.1698 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0167 | 0.0094 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0203 | 0.8718 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0029 | 0.0772 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1481 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0961 | 0.6108 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.1664 | 0.1908 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0029 | 0.0772 | 0.5145 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0565 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0029 | 0.0772 | 0.5145 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.0086 | 0.0098 |
Brugia malayi | MH2 domain containing protein | 0.0117 | 0.4763 | 0.5418 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.1664 | 0.1828 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0145 | 0.0166 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0022 | 0.0025 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0565 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0644 | 0.0739 |
Echinococcus multilocularis | GPCR, family 2 | 0.0015 | 0.0145 | 0.0843 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.1481 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.1481 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.0644 | 0.4263 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0772 | 0.0886 |
Plasmodium vivax | SET domain protein, putative | 0.0029 | 0.0772 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.0644 | 0.4263 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.0145 | 0.0843 |
Echinococcus granulosus | GPCR family 2 | 0.0015 | 0.0145 | 0.0843 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.0565 | 0.5 |
Onchocerca volvulus | 0.0029 | 0.0772 | 0.0137 | |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0772 | 0.4698 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.1481 | 0.1616 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0117 | 0.4763 | 0.5463 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.0644 | 0.0739 |
Schistosoma mansoni | lamin | 0.0026 | 0.0644 | 0.3735 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0772 | 0.4698 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.1481 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.